CORIN STANSFIELD: Open Payments
NPI 1891426078 · SUNBURY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,388 in 77 payments from 16 companies in 2025. Trend: 2023 $928 · 2024 $1,254 · 2025 $1,388
Food & beverage: $1,388
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $346 |
| Novo Nordisk Inc | 20 | $328 |
| PFIZER INC. | 6 | $119 |
| Exact Sciences Corporation | 5 | $106 |
| Lilly USA, LLC | 5 | $99 |
| Phathom Pharmaceuticals, Inc. | 4 | $67 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Esperion Therapeutics, Inc. | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Amgen Inc. | 2 | $39 |
Products named: VRAYLAR, Ozempic, QULIPTA, The Cologuard Plus Collection Kit, ELIQUIS, MOUNJARO, Rybelsus, VOQUEZNA.
Industry payments across PA — which companies pay providers there.
